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Abstract: Polyunsaturated fatty acids (PUFAs)
and leukotriene B4 (LTB4) are involved in many
inflammatory and physiological conditions. The
role of arachidonic acid (AA) and linoleic acid (LA)
in promoting the assembly of reduced nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase
subunits is well known, but the involvement of
LTB4 and other 5-lipoxygenase (5-LO) pathway
metabolites of AA in hydrogen peroxide (H2O2)
production by PUFA-stimulated polymorphonu-
clear leukocytes (PMNs) has not been investigated.
We examined this question by determining H2O2
production as well as phosphorylation and mem-
brane translocation of the p47phox subunit of
NADPH oxidase. Elicited peritoneal PMNs from
rats and from 5-LO-deficient or wild-type mice
were pretreated with or without inhibitors of LT
biosynthesis and antagonists of the receptors for
LTB4 and cysteinyl LTs for 20 min before stimu-
lation with AA (at 5 and 20 M) or LA (at 20 M).
PUFAs elicited H2O2 production in a dose-depen-
dent manner, and pharmacologic or genetic inhi-
bition of LT synthesis decreased H2O2 production
by 40% when compared with untreated controls.
LTB4 was the moiety responsible for H2O2 produc-
tion, as revealed by studies using receptor antago-
nists and its exogenous addition. LTB4 itself also
promoted p47phox phosphorylation and translo-
cation. These results identify a heretofore unrec-
ognized role for activation of 5-LO and subsequent
production of LTB4 in stimulation of PMN NADPH
oxidase activation by PUFAs. J. Leukoc. Biol. 78:
976–984; 2005.
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INTRODUCTION
Polyunsaturated fatty acids (PUFAs) are involved in many
physiological and pathological situations, including alteration
of plasma lipid levels, cardiovascular function, insulin action,
neuronal development, and activation and regulation of the
immune system [1]. These lipids are classified according to the
position of the double bond nearest their methyl () end into
those of the n-3 (-3) and those of the n-6 (-6) series. PUFAs
are essential constituents of mammalian diets, required for
maintenance of normal cell structure and function. Examples
of n-6 PUFAs are linoleic acid (LA; 18:2n-6) and arachidonic
acid (AA; 20:4n-6). AA and LA are liberated from membrane
phospholipids by the action of phospholipase A2 (PLA2) en-
zymes. AA serves the well-characterized role of substrate for
the generation of bioactive eicosanoids, including prostaglan-
dins and leukotrienes (LTs). Besides its role as a precursor for
eicosanoids, endogenous AA may function as an intracellular
signaling molecule [2, 3] or as a cell activator when released
into the extracellular space.
Numerous signaling components have been reported to be
activated by exogenous AA. These include guanosine 5-
triphosphate-binding proteins [4], plasma membrane Ca
channels [5], extracellular signal-regulated kinase 1/2 (ERK
1/2) [6], Raf-1/mitogen-activated protein kinase kinase (MEK)
[7], c-Jun N-terminal kinase [8], phosphatidylinositol 3-kinase
[9], PLC [9], nuclear factor- B [10], and protein kinase C
(PKC) [11]. In neutrophils [polymorphonuclear leukocytes
(PMNs)], it has been suggested that activation of ERK 1/2 and
Raf-1/MEK by AA could be mediated by formation of its
lipoxygenase (LO) metabolic products [6, 7]. One of the most
well-studied actions of AA is the activation of nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase in cell-free
systems as well as intact PMNs [4, 5, 12–19]. The NADPH
oxidase complex is formed by the cytosolic proteins p47phox,
p40phox, p67phox, and Rac-1 or -2 and the membrane-asso-
ciated components gp91phox, p22phox, and Rap-1 [20]. Upon
cell activation, the cytosolic components are phosphorylated by
specific serine kinases. This leads to structural modification of
the phox proteins, allowing their translocation to the cell
membrane [20]. Most activators of NADPH oxidase, such as
cytokines, lipids, and bacteria, act via receptor-mediated sig-
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naling pathways; however, lipids, such as AA, LA, diacylglyc-
erol, or phosphatidic acid, may also interact directly with
p47phox or p67phox proteins by unmasking their membrane-
binding domains [19, 21] or may interact with other relevant
regulatory components [22–27].
AA is converted to LTs by 5-LO, and the major products
formed in PMNs are LTB4 and 5-hydroxy-eicosatetraynoic acid
(5-HETE) [28]. It is important that LTB4 has been shown to
activate NADPH oxidase [29, 30], although the mechanism of
this activation remains unknown. However, we recently dem-
onstrated that in rat alveolar macrophages, LTB4 activates
NADPH oxidase through phosphorylation and translocation of
p47phox to the membrane, a process that was itself dependent
on PKC- activity [31]. It is unclear whether the ability of AA
to activate NADPH oxidase depends, in part, on its metabolism
to LTB4. Conversely, as LTB4 activates cytosolic PLA2 (cPLA2)
[32], it is possible that NADPH oxidase activation depends on
LTB4-stimulated AA. As AA and LTB4 can stimulate Ca

release [33, 34] as well as PLC and PKC activities [9, 11, 30,
35], these actions may affect NADPH oxidase indirectly as
well. Thus, the goals of this work were to evaluate the role of
5-LO metabolites in PUFA-induced NADPH oxidase activa-
tion in PMNs and to determine the molecular mechanisms
involved in these actions. Herein, we report that LTB4 is a
significant mediator of the ability of AA to activate NADPH
oxidase in PMNs. LTB4 participates in NADPH oxidase acti-
vation by modulating p47phox phosphorylation and transloca-
tion to the membrane. To our knowledge, this is the first report
showing that LTB4 is able to directly affect the assembly of
NADPH oxidase components in PMNs.
MATERIALS AND METHODS
Reagents
Dulbecco’s modified Eagle’s medium (DMEM) without phenol red was pur-
chased from Gibco-Invitrogen (Carlsbad, CA). Type IV horseradish peroxidase
(HRP) was purchased from Sigma Chemical Co. (St. Louis, MO). AA, LA,
LTB4, LTC4, LTD4, phorbol myristate acetate (PMA), MK886 [5-LO-activating
protein (FLAP) inhibitor], AA-861 (5-LO inhibitor), MK571 [cysteinyl LT
receptor 1 (cysLT1) antagonist], and diphenyleneiodonium (DPI; NADPH
oxidase-like flavoprotein inhibitor) were purchased from Biomol (Palo Alto,
CA). CP105,696 [LTB4 receptor 1 (BLT1) antagonist] was a generous gift of Dr.
Henry Showell (Pfizer, Groton, CT). Abbott Laboratories (Abbott Park, IL)
provided zileuton. Amplex Red (10-acetyl-3,7-dihydroxyphenoxazine) was
purchased from Molecular Probes (Eugene, OR). Compounds requiring recon-
stitution were dissolved in ethanol or dimethyl sulfoxide. Required dilutions of
all compounds were prepared immediately before use, and equivalent quanti-
ties of vehicle were added to the appropriate controls.
Animals
5-LO knockout (KO; 129-Alox5tm1Fun) [36] and strain-matched wild-type (WT)
sv129 mice were bred in the University of Michigan Unit for Laboratory
Animal Medicine (Ann Arbor) from breeders obtained from Jackson Labora-
tories (Bar Harbor, ME), and female Wistar rats were obtained from Charles
River Laboratories (Portage, MI). The University Committee on Use and Care
of Animals approved animal protocols.
Cell harvest
Glycogen-elicited rat or murine PMNs were obtained following injection of 20
mL 4% glycogen (Sigma Chemical Co.) into the peritoneal cavity. After 5–6 h,
the peritoneal exudates were harvested by lavage with phosphate-buffered
saline (PBS). Contaminating red blood cells were lysed with H2O, and the cells
were washed 2 with PBS. The percentage of PMNs was determined micro-
scopically using a modified Wright-Giemsa stain, and a typical experiment
yielded 90% PMNs.
Cell viability
No experimental compounds or vehicle showed any adverse effects on PMN
viability as determined by a cell-based 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nyl tetrazolium bromide assay (data not shown).
Hydrogen peroxide (H2O2) detection
Rat PMNs (5105/well) were plated in 96-well dishes as described above.
H2O2 production was assessed in a HRP-coupled reaction using Amplex Red
as a probe, according to the manufacturer (Molecular Probes). To assess the
role of 5-LO metabolites in H2O2 production stimulated by PUFAs, the cells
were first pretreated with zileuton, AA-861, MK886, MK571, or CP105,696 for
20 min followed by the addition of the Amplex Red solution containing AA or
LA. The solution containing 50 M Amplex Red reagents and 10 U/mL HRP
was prepared in PBS, 0.1 mL was added to PMNs at 37°C for 30 min, and the
H2O2 levels were determined colorimetrically (absorbance at 560 nm).
LTB4 measurement
Rat PMNs (5105 cells/well) were cultured in 96-well plates in DMEM.
Cultures were then incubated for 5, 15, and 30 min with 20 M AA to
stimulate LT production. Culture supernatants were collected, and LTB4 levels
were quantified by enzyme immunoassay, according to the manufacturer (As-
say Designs, Ann Arbor, MI).
Fractionation, immunoprecipitation,
and Western blotting
PMNs (1107) were plated in six-well tissue-culture dishes and pretreated
with AA-861 or CP105,696 for 20 min, followed by stimulation for 5 min with
20 M AA or vehicle control. After this, PMNs were lysed by sonication in
ice-cold lysis buffer containing 150 mM Tris-HCl (pH 8.0), 100 mM NaCl, 1
mM sodium orthovanodate, 1 mM phenylmethylsulfonyl fluoride, 50 mM NaF,
and 1 g/mL leupeptin, followed by ultracentrifugation at 100,000 g for 20 min
at 4°C. The cytosolic (soluble) fraction was harvested, and the membrane
(insoluble) fraction was washed and subjected to another ultracentrifugation
step as described above. The resulting pellet was resuspended in lysis buffer
and sonicated. Protein concentrations were determined by a modified Coomas-
sie dye-binding assay (Pierce Chemical Co., Rockford, IL). The cytosolic
fraction was used for immunoprecipitation as described previously [37] with
some modifications. The fraction was incubated overnight at 4°C with anti-
p47phox antibody (1:80; Upstate Biotechnology, Lake Placid, NY). Protein
A-Sepharose was added to each sample and incubated for 3 h with rotation at
4°C. The beads were washed briefly 3 with lysis buffer without Triton X-100,
and samples containing 20 g protein were separated on 8% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis gels and then transferred to nitro-
cellulose membranes. Following blocking with 5% nonfat milk, membranes
were probed with antibodies directed against p47phox (1:500 dilution; Upstate
Biotechnology) or antiphosphoserine (1:900; KI-191, clone 1C8; Biomol) for 90
min, followed by peroxidase-conjugated goat anti-rabbit (Amersham, Piscat-
away, NJ) or anti-mouse secondary (1:5000; Zymed, South San Francisco, CA)
and developed using enhanced chemiluminescence detection (Amersham).
Statistical analysis
Data are represented as mean 	 SE and were analyzed with the Prism 3.0
statistical program (GraphPad Software, San Diego, CA). Comparisons between
two experimental groups were performed with Student’s t-test. Comparisons
among more than or equal to three experimental groups were performed with
ANOVA followed by the Bonferroni analysis. Differences were considered
significant if P  0.05. All experiments were performed on more than or equal
to three separate occasions unless otherwise specified.
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RESULTS
PUFAs induce H2O2 release in glycogen-elicited
PMNs via NADPH oxidase
To determine if PUFAs activate NADPH oxidase (as deter-
mined by H2O2 production), we performed dose-response ex-
periments using AA or LA. As shown in Figure 1, A and B,
AA and LA induced H2O2 generation in a dose-dependent
manner. At the plateau dose (20 M) of either PUFA, we
observed the production of approximately five times more H2O2
than by untreated cells. As concentrations of AA above 20 M
can induce cell necrosis [38], we used 20 M of both PUFAs
for subsequent experiments.
Reactive oxygen intermediates (ROI) may be generated by a
variety of sources, including enzymes other than NADPH ox-
idase [39, 40]. To determine if ROI produced during PUFA
activation is from NADPH oxidase activation, we pretreated
PMNs with DPI, a flavoprotein inhibitor that has relative
specificity for NADPH oxidase at a concentration of 10 M,
followed by addition of 20 M AA or LA. Our data show that
the major source of ROI during AA or LA stimulation is
through activation of NADPH oxidase, as H2O2 production was
abolished completely in DPI-treated as compared with un-
treated cells (Fig. 2).
NADPH oxidase activation by PUFAs is partially
dependent on 5-LO activity
The role of cPLA2 activation and AA release in NADPH
oxidase activation is well-established [18, 41]. As AA is the
substrate for 5-LO, and 5-LO metabolites are themselves able
to induce NADPH oxidase activation [29, 30, 42], we sought to
determine if such products are important in mediating the
effects of PMN stimulation by PUFAs.
Our first approach was to determine whether endogenous
5-LO metabolites play a role in PUFA-stimulated H2O2 pro-
duction. Rat PMNs were pretreated with either of two inhibitors
of LT synthesis, namely, the 5-LO inhibitor zileuton (10 M) or
the FLAP inhibitor MK886 (1 M), for 20 min before activa-
tion with AA or LA (20 M). As observed in Figure 3, A and
C, zileuton and MK886 treatment decreased by 40% the AA-
or LA-induced H2O2 production as compared with untreated
cells. Similar experiments using cells from 5-LO-deficient
mice confirmed these results (Fig. 3, B and D). It is interesting
that when the PMNs were stimulated with a lower dose of AA
(5 M; a concentration of AA that is perhaps more relevant to
its possible function as an endogenous second messenger), the
role of endogenous 5-LO metabolites in inducing H2O2 gener-
ation was even more pronounced. For example, stimulation of
H2O2 generation with 20 M AA was inhibited by 40% by
Fig. 1. PUFAs stimulate PMN H2O2 release in a dose-dependent manner. H2O2 from glycogen-elicited rat PMNs was measured 30 min after stimulation with
AA (A) or LA (B). H2O2 concentrations were determined using Amplex Red as a probe as described in Materials and Methods. Data represent mean 	 SE from
quadruplicate values from one experiment representative of a total of four. *, P 
 0.05, versus control by ANOVA.
Fig. 2. PMN H2O2 production in response to PUFAs is dependent on NADPH
oxidase activity. PMNs were treated with the NADPH oxidase inhibitor DPI
(10 M) for 20 min and then stimulated for 30 min with 20 M AA or 20 M
LA. H2O2 production was determined using Amplex Red as a probe, as
described in Materials and Methods. Data represent mean 	 SE from quadru-
plicate values from one experiment representative of a total of four. *, P 

0.05, versus control and #, P 
 0.05 versus PUFA alone by ANOVA.
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the 5-LO inhibitor AA-861, but with 5 M AA, the inhibition
was 75% when compared with untreated control (control,
2.93	0.129; AA, 11.23	0.134; AAAA-861, 5.080	0.240
nM H2O2/210
5 PMN/30 min; P
0.05 for AAAA-861 vs.
AA alone). Taken together, these data indicate that H2O2 produc-
tion stimulated by PUFAs in glycogen-elicited PMNs is depen-
dent, in part, on endogenous 5-LO products.
NADPH oxidase activation by endogenous
5-LO products involves the BLT1 receptor
The major products of the 5-LO pathway include LTB4 as well
as the cysteinyl LTs C4, D4, and E4. Both act in leukocytes
primarily through BLT1 or cysLT1 receptors. To evaluate
which of these LTs are involved in the activation of NADPH
oxidase by PUFAs, we pretreated cells with the BLT1 antag-
onist CP105,696 (10 M), or the cysLT1 antagonist MK571
(10 M) for 20 min before PUFA stimulation. Antagonism of
BLT1 abolished H2O2 secretion in PMNs stimulated with AA
or LA. In contrast, PMNs pretreated with the cysLT1 antagonist
MK571 did not demonstrate altered H2O2 production when
compared with the untreated group (Fig. 4, A and B). To
exclude the possibility that CP105,696 was merely acting as a
H2O2 scavenger in this circumstance, we assayed a range of
concentrations of added reagent H2O2 in the presence or
absence of 10 M CP105,696 and detected no influence of the
antagonist (data not shown). Furthermore, we examined if the
BLT1 antagonist influenced NADPH oxidase activation in re-
sponse to the strong stimulus PMA, and we observed no effect
of the antagonist (data not shown). To investigate the role of
BLT1 in PMNs stimulated with 5 M AA, we pretreated
PMNs with the BLT1 antagonists CP105,696 (10 M) or
U75302 (1 M) followed by AA stimulation. As observed
above, the effects of both antagonists were again more evident
at this lower AA concentration (control, 2.93	0.129; AA,
Fig. 3. H2O2 production in response to PUFAs in
LT-deficient PMNs. Glycogen-elicited rat PMNs
were pretreated with the 5-LO inhibitor zileuton (10
M) or the FLAP inhibitor MK886 (1 M) for 20
min and then stimulated for 30 min with 20 M AA
(A) or 20 M LA (C). Glycogen-elicited PMNs from
WT or 5-LO KO mice were stimulated with AA (B)
or LA (D) for 30 min. H2O2 concentrations were
determined using Amplex Red as a probe as de-
scribed in Materials and Methods. Data represent
the mean 	 SE of quadruplicate values from one
experiment representative of a total of four. *, P 

0.05 versus control and #, P 
 0.05 versus PUFA
alone by ANOVA.
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11.23	0.134; AACP105,696, 2.700	0.385; AAU75302,
6.725	0.125 nM H2O2/210
5 PMN/30 min. P
0.05 for
AACP105,696 or AAU75302 vs. AA alone).
To confirm that LTB4 itself can increase NADPH oxidase
activity in rat PMNs, we incubated cells with increasing con-
centrations of LTB4 or cysteinyl LTs (LTC4 and LTD4). The
stimulation of PMNs with 0.01–10 nM LTB4 induced H2O2
secretion in a dose-dependent manner (Fig. 5A). However, we
observed no H2O2 production in PMNs stimulated by cysLTs at
any concentration tested (10–1000 nM LTC4 or LTD4; data not
shown). Thus, our results show that only exogenous LTB4 can
induce NADPH oxidase activation in PMNs.
To determine the kinetic relationship between LTB4 produc-
tion and H2O2 generation in response to exogenous AA, we
performed a time-course experiment in PMNs stimulated with
20 M AA. LTB4 production was detected within 5 min of AA
addition, appeared to plateau at 15 min, and increased once
again by 30 min. By contrast, H2O2 demonstrated an initial lag
period, until an increase could be observed between 5 and 15
min, which increased further by 30 min (Fig. 5B). Thus, our
Fig. 4. Role of LT receptors in PMN H2O2 production by PUFAs. Glycogen-elicited rat PMNs were treated with the BLT1 antagonist CP105,696 (10 M) or the
cysLT1 antagonist MK571 (10 M) and then stimulated for 30 min with 20 M AA (A) or 20 M LA (B). H2O2 production was determined using Amplex Red
as a probe as described in Materials and Methods. Data represent mean 	 SE of quadruplicate values from one experiment representative of a total of four. *, P

 0.05 versus control and # P 
 0.05, versus PUFA alone by ANOVA.
Fig. 5. AA stimulates LTB4 production followed by H2O2 secretion in PMN from rats. (A) H2O2 levels were measured as described in Materials and Methods
after stimulation with different LTB4 concentrations. (B) LTB4 and H2O2 levels were measured as described in Materials and Methods in PMN supernatants at
different time-points following addition of 20 M AA. Data represent mean 	 SE of quadruplicate values from one experiment representative of a total of four. *,
P 
 0.05 versus control by ANOVA.
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results indicate that LTB4 production precedes NADPH oxi-
dase activation in AA-stimulated PMNs, a temporal relation-
ship consistent with the possibility that the former response
contributes to the latter.
Next, we wished to investigate whether it was possible to
restore H2O2 secretion with exogenous LTB4 in PMNs treated
with inhibitors of endogenous LT synthesis and if the LTB4
effect was a result of interaction with the BLT1 receptor. We
therefore pretreated PMNs for 20 min with the 5-LO inhibitor
AA-861 (10 M; Fig. 6A) or the BLT1 antagonist CP105,696
(10 M; Fig. 6B), followed by stimulation with AA and/or
LTB4. Our results show that exogenous LTB4 restored the
inhibition of H2O2 generation in PMNs treated with the 5-LO
inhibitor. In contrast, the addition of LTB4 to AA-treated PMNs
incubated with the BLT1 antagonist did not overcome this
inhibition. These results indicate that endogenous LTB4 is
important in NADPH oxidase activation by AA, and this effect
is mediated by interaction with the BLT1 receptor.
LTB4 induces p47phox phosphorylation and
translocation in AA-stimulated PMNs
As our data identified a role for LTB4 in AA activation of
NADPH oxidase, we sought to determine the relevant molec-
ular mechanism. We first evaluated if LTB4 contributed to
p47phox phosphorylation in PMNs stimulated by AA. As can
be observed in Figure 7A, AA elicited phosphorylation of
p47phox, and pretreatment of PMNs with a 5-LO inhibitor as
well as a BLT1 antagonist decreased AA-induced p47phox
phosphorylation. In addition, LTB4 itself induced p47phox
phosphorylation. As p47phox translocation is dependent on
phosphorylation in some cell types [43], we evaluated the
effects of a 5-LO inhibitor and a BLT1 antagonist on this
phenomenon in AA-stimulated PMNs. Our results show that
5-LO inhibition as well as BLT1 antagonism inhibited p47phox
translocation to the membrane fraction, indicating that endog-
enous LTB4 contributes to p47phox translocation in PMNs
stimulated by AA (Fig. 7C). In addition, we observed the same
profile in LA-stimulated cells (data not shown). To directly test
Fig. 6. Role of BLT1 receptor in mediating H2O2 stimulation. Glycogen-elicited rat PMNs were treated with the 5-LO inhibitor AA-861 (10 M; A) or the BLT1
antagonist CP105,696 (10 M; B) and then stimulated for 30 min with 20 M AA and/or 10 nM LTB4. H2O2 production was determined using Amplex Red as
a probe as described in Materials and Methods. Data represent mean 	 SE of quadruplicate values from one experiment representative of a total of four. *, P 

0.05 versus control; #, P 
 0.05 versus AA; and &, P 
 0.05 versus LTB4 by ANOVA.
Fig. 7. AA induces phosphorylation and translocation of p47phox in glyco-
gen-elicited rat PMNs in a 5-LO- and BLT1-dependent manner. PMNs
(4106/well) were pretreated or not with CP105,696 or AA-861, stimulated by
20 M AA or 10 nM LTB4 for 5 min, and then harvested and fractionated as
described in Materials and Methods. The cytosolic fraction was immunopre-
cipited, and immunoprecipited protein was immunoblotted using antiphospho-
serine (1:900), and phosphorylated protein is designated p-p47phox (A). The
total cytosolic fraction (B) and membrane fraction (C) were probed for total (T)
p47phox (1:500). Experiment is representative of a total of two.
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the capacity of LTB4 to promote NADPH oxidase activation, we
stimulated PMNs with 10 nM LTB4 and observed phosphory-
lation and membrane translocation of p47phox. This finding
therefore extends to PMNs what we have recently demonstrated
with LTB4 in alveolar macrophages [31]. Together, these re-
sults suggest that LTB4 is partially responsible for the NADPH
oxidase activation induced by AA, through effects on phos-
phorylation as well as membrane translocation of p47phox.
DISCUSSION
This study establishes a role for LTB4 in NADPH oxidase
activation by exogenous PUFAs in elicited rodent PMNs. Spe-
cifically, our results show that AA and LA are able to induce
secretion of H2O2 in elicited PMNs; NADPH oxidase is the
major source of H2O2 in PUFA-stimulated PMNs; PUFA-
induced H2O2 generation is dependent on 5-LO activity and
LTB4 biosynthesis, and effects of LTB4 are mediated by the
BLT1 receptor; and LTB4 contributes to p47phox phosphory-
lation and membrane translocation in AA-stimulated PMNs.
PUFAs are involved in inflammatory conditions, such as
modulation of vascular contraction, chemotaxis, cell adhesion
and diapedesis, cell activation, and cell death [44]. AA is a
pleiotropic lipid involved in inflammatory and physiological
situations. A role for AA in inflammation has been suggested
by studies showing that AA increases chemotaxis, granule
release, and effector functions such as phagocytosis, microbi-
cidal activity, and release of ROI in PMNs [45]. The role of AA
as a second messenger [2] and its ability to activate NADPH
oxidase are well-known [4, 5, 12–19]. In addition, AA is the
precursor of bioactive lipids including prostanoids and LTs,
which are themselves able to induce cell activation. Upon
activation, the major AA metabolites produced by PMNs are
LTB4 and 5-hydroxy-5-HETE [32], but the respective roles of
AA and its metabolic products in cell signaling are incom-
pletely understood. Thus, we sought to evaluate the role of
these 5-LO products in AA and LA stimulation of NADPH
oxidase activation.
We first asked if PUFAs activate NADPH oxidase by them-
selves or via formation of metabolic products. As expected [18,
19], both PUFAs were able to induce H2O2 release dose-
dependently to a similar extent at concentrations similar to
those observed previously. To address the role of 5-LO metab-
olites in AA- or LA-stimulated PMNs, we inhibited 5-LO or
FLAP (both essential for LT synthesis [46]), and we observed
an inhibition in H2O2 production of 40% when compared
with the untreated control. This effect was confirmed using
cells obtained from genetically 5-LO-deficient mice. Although
ROI can be generated by a variety of enzymatic sources [47],
the ability of the NADPH oxidase-like flavoprotein inhibitor
DPI to completely attenuate ROI production in AA- or LA-
stimulated PMNs suggests that PUFA effects occurred exclu-
sively through activation of NADPH oxidase.
Our results strongly suggest that AA and LA act to increase
5-LO activity, which results in NADPH oxidase activation.
These results are consistent with studies in AA-stimulated
guinea pig eosinophils pretreated with the AA congener eico-
satetraynoic acid (ETYA), which prevents the further metabo-
lism of AA [48]. By contrast, Pompeia et al. [38] demonstrated
that O2
– production by HL-60 cells stimulated with AA was
independent of 5-LO metabolites. Regarding the dependence
on AA metabolites observed with exogenous LA stimulation,
Alzoghaibi et al. [49] showed that LA-induced interleukin-8
production in human intestinal smooth muscle cells was de-
pendent on 5-LO and cyclooxygenase metabolites. To our
knowledge, however, this is the first report showing that LA
induction of NADPH oxidase activity depends on 5-LO me-
tabolites. That endogenous 5-LO activity is important for acti-
vating NADPH oxidase has been demonstrated in PMNs stim-
ulated by myriad agonists. Maridonneau-Parini et al. [50]
showed that opsonized zymosan, but not PMA, induced O2
–
generation in a manner dependent on 5-LO and cyclooxygen-
ase products in human PMNs. Furthermore, it was observed
that 5-LO metabolites are necessary for NADPH oxidase acti-
vation in PMNs stimulated by platelet-activating factor, formyl-
Met-Leu-Phe, PMA, and A23187 [51]. Although the role of
5-LO metabolites in NADPH oxidase activation is recognized,
the importance of individual LTs in PUFA-induced NADPH
oxidase activation is not. When we pretreated PMNs with BLT1
or cysLT1 receptor antagonists followed by stimulation with
AA or LA, we observed that only the BLT1 antagonist abol-
ished the H2O2 secretion in PUFA-stimulated PMNs. Like-
wise, only LTB4, but not cysLTs, was capable of stimulating
secretion of H2O2 in PMNs. To confirm that the effects of
PUFAs were dependent on LTB4 interaction with BLT1, we
performed “add back” experiments. The first approach was to
pretreat cells with AA-861 and then add AA with or without
LTB4. Our experiments clearly show that in 5-LO-inhibited
cells, the addition of LTB4 restored the PMN ability to secrete
H2O2. We confirmed that the LTB4 effects are mediated by
interaction with BLT1, as LTB4 addition was ineffective in
BLT1 antagonist-treated cells. At lower (i.e., 5 M) AA con-
centrations more relevant to those produced endogenously,
which might function as second messengers, we observed an
even more prominent dependence on 5-LO products and BLT1
in AA-stimulated PMNs. This could reflect the ability of lower
doses of AA to activate classical PKC [11] or Ca release [9],
both of which are known to be important in the activation of
5-LO [46].
Results with 5-LO inhibitors and 5-LO KO cells as well as
a BLT1 antagonist implicate 5-LO metabolism/BLT1 signaling
in NADPH oxidase activation by AA and LA. However, we
could only measure immunoreactive LTB4 production in PMNs
stimulated with AA and not with LA. These results are con-
sistent with an alternative LT derivative of LA other than LTB4
interacting with BLT1 to affect NADPH oxidase, but we are
aware of no precedent regarding such a possibility. It will be of
interest to clarify this in future studies.
That PMNs respond predominantly to LTB4, but not cysLTs,
is in agreement with previous findings from our laboratory and
others. Mancuso et al. [52] showed that LTB4, but not cysLTs,
increased phagocytosis of opsonized Klebsiella pneumoniae in
human PMNs. In addition, Palmblad et al. [53] showed that
only LTB4 induced NADPH oxidase activation in eosinophils
and PMNs. However, Larfars et al. [42] demonstrated that
LTB4 and cysLTs were able to induce nitric oxide production
in human PMNs. In our experimental system, a role for 5-LO
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products in PUFA stimulation of NADPH oxidase was confined
to LTB4 and its interaction with BLT1.
Although AA promotes p47phox translocation in human
monocytes, its ability to enhance phosphorylation of this mol-
ecule has been the subject of conflicting reports [19]. In
eosinophils, LTB4 stimulated H2O2 production independent of
AA release [29], and this effect was dependent on PKC, PLC,
and Ca [30]. The molecular mechanism by which LTB4
activates NADPH oxidase activation in PMNs is unclear. Thus,
we sought to determine the effects of LTB4 on p47phox phos-
phorylation and translocation in AA-stimulated PMNs. Our
results show that inhibition of 5-LO metabolism or antagonism
of BLT1 decreased phosphorylation and translocation of
p47phox in AA-stimulated cells and that exogenous LTB4 was
able to increase its phosphorylation and translocation. We have
observed similar effects of LA. Together, our results suggest
that LTB4 contributes to activation of the p47phox cytosolic
component of NADPH oxidase in PUFA-stimulated PMNs.
Activation of p47phox is regulated by the action of a variety
of kinases, including PKC [43]. PUFAs act as second messen-
gers, in part, by stimulating these kinases [2]. Our present data
are the first to implicate 5-LO products in PUFA-induced
p47phox activation. The plausibility of such a role for LTB4 is
emphasized by our recent demonstration in macrophages that
LTB4 elicits activation of p47phox via effects on the upstream
kinase PKC- [31].
In conclusion, our experiments show that n-6 PUFAs acti-
vate NADPH oxidase in glycogen-elicited PMNs, and this
activation is partially dependent on 5-LO activity, LTB4 syn-
thesis, and BLT1 signaling. Indeed, we demonstrated that
LTB4 is required for two essential aspects of NADPH oxidase
activation, namely, phosphorylation and translocation of
p47phox, in PMNs stimulated by AA. This study presents a
new model of NADPH oxidase activation by PUFAs, and the
identification of a role for LTB4 suggests possible therapeutic
interventions targeting this lipid mediator for inflammatory
conditions in which ROI production is responsible for tissue
injury.
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